206 related articles for article (PubMed ID: 15704683)
61. The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002).
Vela-Navarrete R; Gonzalez-Enguita C; Garcia-Cardoso JV; Manzarbeitia F; Sarasa-Corral JL; Granizo JJ
BJU Int; 2005 Nov; 96(7):1045-8. PubMed ID: 16225526
[TBL] [Abstract][Full Text] [Related]
62. Role of free to total prostate specific antigen ratio in serum in the diagnosis of prostatic enlargement.
Bhuiyan AK; Kibria SA; Subhan SS
Bangladesh Med Res Counc Bull; 2004 Aug; 30(2):51-9. PubMed ID: 15813483
[TBL] [Abstract][Full Text] [Related]
63. [Transurethral prostatectomy with the bipolar plasma kinetic technique for benign prostate hyperplasia: a report of 297 cases].
Song XS; Che XY; Wang JB; He ZZ; Jiang T; Yin JB; Zhang RK
Zhonghua Nan Ke Xue; 2005 Feb; 11(2):140-1, 144. PubMed ID: 15755037
[TBL] [Abstract][Full Text] [Related]
64. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
[TBL] [Abstract][Full Text] [Related]
65. Outcome of salvage radiotherapy for biochemical failure after radical prostatectomy with or without hormonal therapy.
Cheung R; Kamat AM; de Crevoisier R; Allen PK; Lee AK; Tucker SL; Pisters L; Babaian RJ; Kuban D
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):134-40. PubMed ID: 16111581
[TBL] [Abstract][Full Text] [Related]
66. Lack of effects of a lyposterolic extract of Serenoa repens on plasma levels of testosterone, follicle-stimulating hormone, and luteinizing hormone.
Casarosa C; Cosci di Coscio M; Fratta M
Clin Ther; 1988; 10(5):585-8. PubMed ID: 2485240
[TBL] [Abstract][Full Text] [Related]
67. BXL628, a novel vitamin D3 analog arrests prostate growth in patients with benign prostatic hyperplasia: a randomized clinical trial.
Colli E; Rigatti P; Montorsi F; Artibani W; Petta S; Mondaini N; Scarpa R; Usai P; Olivieri L; Maggi M;
Eur Urol; 2006 Jan; 49(1):82-6. PubMed ID: 16310924
[TBL] [Abstract][Full Text] [Related]
68. Radiotherapy for rectal cancer is associated with reduced serum testosterone and increased FSH and LH.
Bruheim K; Svartberg J; Carlsen E; Dueland S; Haug E; Skovlund E; Tveit KM; Guren MG
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):722-7. PubMed ID: 18262088
[TBL] [Abstract][Full Text] [Related]
69. Association between lower urinary tract symptoms and serum levels of sex hormones in men.
Miwa Y; Kaneda T; Yokoyama O
Urology; 2008 Sep; 72(3):552-5. PubMed ID: 18597822
[TBL] [Abstract][Full Text] [Related]
70. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels.
Faydaci G; Bilal E; Necmettin P; Fatih T; Asuman O; Uğur K
Aging Male; 2008 Dec; 11(4):189-92. PubMed ID: 19172550
[TBL] [Abstract][Full Text] [Related]
71. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
[TBL] [Abstract][Full Text] [Related]
72. [Antagonistic effect of 3'-daidzein sulfonate sodium on prostatic hyperplasia in mice].
Huang YS; Zeng J; Huang YP; Qiu F; Ye HY; Wang SR
Zhonghua Nan Ke Xue; 2007 May; 13(5):387-90. PubMed ID: 17569249
[TBL] [Abstract][Full Text] [Related]
73. [Transurethral prostatectomy with the bipolar plasmakinetic technique for benign prostate hyperplasia: a report of 712 cases].
Che XY; Song XS; Wu DJ; Wang FP; Wang QF; Wang JB
Zhonghua Nan Ke Xue; 2009 May; 15(5):449-51. PubMed ID: 19514560
[TBL] [Abstract][Full Text] [Related]
74. Photoselective vaporization of the prostate in the treatment of benign prostatic hyperplasia.
Fu WJ; Hong BF; Yang Y; Cai W; Gao JP; Wang CY; Wang XX
Chin Med J (Engl); 2005 Oct; 118(19):1610-4. PubMed ID: 16232345
[TBL] [Abstract][Full Text] [Related]
75. Androgens in patients with benign prostatic hyperplasia before and after prostatectomy.
Vermeulen A; De Sy W
J Clin Endocrinol Metab; 1976 Dec; 43(6):1250-4. PubMed ID: 63468
[TBL] [Abstract][Full Text] [Related]
76. [Thulium laser resection of prostate-tangerine technique in treatment of benign prostate hyperplasia].
Xia SJ; Zhang YN; Lu J; Sun XW; Zhang J; Zhu YY; Li WG
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(45):3225-8. PubMed ID: 16405847
[TBL] [Abstract][Full Text] [Related]
77. Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age.
Martínez-Jabaloyas JM; Queipo-Zaragozá A; Rodríguez-Navarro R; Queipo-Zaragozá JA; Gil-Salom M; Chuan-Nuez P
Eur Urol; 2007 Dec; 52(6):1760-7. PubMed ID: 17590268
[TBL] [Abstract][Full Text] [Related]
78. Catheter-free 120W lithium triborate (LBO) laser photoselective vaporization prostatectomy (PVP) for benign prostatic hyperplasia (BPH).
Spaliviero M; Araki M; Page JB; Wong C
Lasers Surg Med; 2008 Oct; 40(8):529-34. PubMed ID: 18798292
[TBL] [Abstract][Full Text] [Related]
79. The effects of zinc deficiency and testosterone supplementation on leptin levels in castrated rats and their relation with LH, FSH and testosterone.
Ozturk A; Baltaci AK; Mogulkoc R; Oztekin E; Kul A
Neuro Endocrinol Lett; 2005 Oct; 26(5):548-54. PubMed ID: 16264402
[TBL] [Abstract][Full Text] [Related]
80. [Effect of dutasteride on reduction of plasma DHT following finasteride therapy in patients with benign prostatic hyperplasia].
Botto H; Lan O; Poulain JE; Comenducci A
Prog Urol; 2005 Dec; 15(6):1090-5. PubMed ID: 16429658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
